Sitamaquine Hydrochloride

N/A

Report date: 2023/04/21 14:28:30
NME

Base Information

Drug NameSitamaquine Hydrochloride
Drug Alias Namesitamaquinum盐酸西他马喹西他马喹盐酸盐sitamaquine西他马喹 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHIV InfectionsLeishmaniasis, VisceralPneumonia, Pneumocystis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWalter Reed Army Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHIV InfectionsLeishmaniasis, VisceralPneumonia, Pneumocystis

Other Information

ATC CodeN/A
Related LinksDrugBank